(260 days)
No
The description focuses on the mechanical and electrical functions of a steerable catheter for recording and stimulation, with no mention of AI or ML for data analysis, interpretation, or control.
No
The device is described as a diagnostic tool for recording intracardiac signals and mapping atrial regions, rather than performing therapeutic interventions.
Yes
The Intended Use / Indications for Use section explicitly states it is "used for recording intracardiac signals and cardiac stimulation during diagnostic studies" and "to map the atrial regions of the heart." The Device Description also refers to it as a "Steerable Diagnostic Electrophysiology (EP) Catheter."
No
The device description clearly describes a physical catheter with mechanical components (distal end with variable loop diameter, deflectable shaft steering mechanism, rotating knob, thumb control) and the performance studies include extensive hardware testing (Biocompatibility, Functional Testing, Mechanical Characteristics, Electrical Safety Testing, etc.).
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used outside of the body.
- Device Function: The description clearly states the device is a "steerable electrophysiology catheter used for recording intracardiac signals and cardiac stimulation during diagnostic studies." This means it is used inside the body to interact directly with the heart tissue.
- Intended Use: The intended use is to "map the atrial regions of the heart," which is an in-vivo procedure.
Therefore, this device is an in-vivo diagnostic device, not an in-vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Reprocessed Inquiry Optima and Inquiry Optima Plus Catheter is a steerable electrophysiology catheter used for recording intracardiac signals and cardiac stimulation during diagnostic studies. The reprocessed Inquiry Optima catheters are to be used to map the atrial regions of the heart.
Product codes
NLH
Device Description
The Reprocessed Inquiry Optima and Inquiry Optima Plus Steerable Diagnostic Electrophysiology (EP) Catheter incorporates both a distal end with a variable loop diameter, which allows selection of diameters within a specific range, and a deflectable shaft steering mechanism. The diameter of the distal loop may be contracted or expanded by turning the rotating knob. The distal shaft may be deflected by pushing and pulling the thumb control.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
atrial regions of the heart
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench and laboratory testing was conducted to demonstrate performance (safety and effectiveness) of the Reprocessed Inquiry Optima and Inquiry Optima Plus Steerable Diagnostic EP Catheter. This included the following:
- Biocompatibility
- Cleaning Validation
- Sterilization Validation
- Functional Testing
- Visual Inspection
- Dimensional Verification
- Electrical Continuity and Resistance
- Simulated Use
- Mechanical Characteristics
- Electrical Safety Testing
- Dielectric and Current Leakage
- Packaging Validation
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1220 Electrode recording catheter or electrode recording probe.
(a)
Identification. An electrode recording catheter or an electrode recording probe is a device used to detect an intracardiac electrocardiogram, or to detect cardiac output or left-to-right heart shunts. The device may be unipolar or multipolar for electrocardiogram detection, or may be a platinum-tipped catheter which senses the presence of a special indicator for cardiac output or left-to-right heart shunt determinations.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
November 2, 2016
Innovative Health, LLC. Rafal Chudzik VP, R&D and Operations 1435 North Hayden Road, Suite 100 Scottsdale, AZ 85257
Re: K160421
Trade/Device Name: Reprocessed Inquiry Optima Plus Steerable Diagnostic EP Catheter, Reprocessed Inquiry Optima Steerable Diagnostic EP Catheter (see Enclosed Model List) Regulation Number: 21 CFR 870.1220 Regulation Name: Electrode Recording Catheter Or Electrode Recording Probe Regulatory Class: Class II Product Code: NLH
Dated: October 4, 2016
Received: October 5, 2016
Dear Rafal Chudzik:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Mache Jellson
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
| Description | Item
Number | Number of
Electrodes | Electrode
Spacing
(mm) | French
Size | Loop Diameter
(mm) | Catheter
Length
(cm) |
|--------------------------------------------------|----------------|-------------------------|------------------------------|----------------|-----------------------|----------------------------|
| Inquiry Optima Plus
Diagnostic EP
Catheter | 81717 | 24 | 1-4.5-1 | 7 | 15-25 | 110 |
| Inquiry Optima
Diagnostic EP
Catheter | 81683 | 20 | 1-4.5-1 | 7 | 15-25 | 110 |
| Inquiry Optima
Diagnostic EP
Catheter | 81659 | 20 | 1-4.5-1 | 7 | 15-25 | 110 |
| Inquiry Optima
Diagnostic EP
Catheter | 81687 | 10 | 7 | 7 | 15-25 | 110 |
| Inquiry Optima
Diagnostic EP
Catheter | 81767 | 10 | 7 | 7 | 15-25 | 110 |
Table 1: K160421 List of Models in Scope
3
Indications for Use
510(k) Number (if known) K160421
Device Name
Reprocessed Inquiry Optima and Inquiry Optima Plus Steerable Diagnostic Electrophysiology Catheter
Indications for Use (Describe)
The Reprocessed Inquiry Optima and Inquiry Optima Plus Catheter is a steerable electrophysiology catheter used for recording intracardiac signals and cardiac stimulation during diagnostic studies. The reprocessed Inquiry Optima catheters are to be used to map the atrial regions of the heart.
Type of Use (Select one or both, as applicable)
| ☒ Prescription Use (Part 21 CFR 801 Subpart D) |
|---|
| ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
SECTION 5: 510(k) SUMMARY
As required by 21 CFR 807.92(c)
Submitter's Name and Address:
Innovative Health, LLC. 1435 N. Hayden Road, Suite 100 Scottsdale, AZ 85257
Contact Name and Information:
Rafal Chudzik Director of Engineering (480) 525-6006 (office) (844) 965-9359 (fax) rchudzik@innovative-health.com
Date prepared:
February 12, 2016
Device Information:
Trade/Proprietary Name:
Common Name: Classification Name: Classification Number: Product Code:
Reprocessed Inquiry Optima and Inquiry Optima Plus Steerable Diagnostic Electrophysiology Catheter Diagnostic Electrophysiology Catheter Catheter, Recording, Electrode, Reprocessed Class II, 21 CFR 870.1220 NLH
Predicate Device:
| 510(k)
| Number | 510(k) Title | Manufacturer |
|---|---|---|
| K060757 | Inquiry Optima Plus Steerable Electrophysiology | |
| Catheter | Irvine Biomedical, Inc. | |
| K042775 | Inquiry AFocus, Inquiry AFocus II and Inquiry | |
| Optima Steerable Electrophysiology Catheter | Irvine Biomedical, Inc. | |
| K961924 | IBI-1100 Steerable Electrophysiology Catheter | |
| System | Irvine Biomedical, Inc. |
Reference Device:
| 510(k)
| Number | 510(k) Title | Reprocessor |
|---|---|---|
| K112232 | Reprocessed Electrophysiology Catheters | Stryker Sustainability |
| Solutions |
De vice De scription:
The Reprocessed Inquiry Optima and Inquiry Optima Plus Steerable Diagnostic Electrophysiology (EP) Catheter incorporates both a distal end with a variable loop diameter, which allows selection of diameters within a specific range, and a deflectable
5
shaft steering mechanism. The diameter of the distal loop may be contracted or expanded by turning the rotating knob. The distal shaft may be deflected by pushing and pulling the thumb control.
| Description | Item
Number | Number of
Electrodes | Electrode
Spacing
(mm) | French
Size | Loop Diameter
(mm) | Catheter
Length
(cm) |
|--------------------------------------------------|----------------|-------------------------|------------------------------|----------------|-----------------------|----------------------------|
| Inquiry Optima Plus
Diagnostic EP
Catheter | 81717 | 24 | 1-4.5-1 | 7 | 15-25 | 110 |
| Inquiry Optima
Diagnostic EP
Catheter | 81683 | 20 | 1-4.5-1 | 7 | 15-25 | 110 |
| Inquiry Optima
Diagnostic EP
Catheter | 81659 | 20 | 1-4.5-1 | 7 | 15-25 | 110 |
| Inquiry Optima
Diagnostic EP
Catheter | 81687 | 10 | 7 | 7 | 15-25 | 110 |
| Inquiry Optima
Diagnostic EP
Catheter | 81767 | 10 | 7 | 7 | 15-25 | 110 |
The item numbers included in the scope of this submission are as follows:
Table 5.1:Device Scope
Indications for Use:
The Reprocessed Inquiry Optima and Inquiry Optima Plus Catheter is a steerable electrophysiology catheter used for recording intracardiac signals and cardiac stimulation during diagnostic electrophysiologic studies. The reprocessed Inquiry Optima catheters are to be used to map the atrial regions of the heart.
Technological Characteristics:
The purpose, design, materials, function, and intended use of the Reprocessed Inquiry Optima and Inquiry Optima Plus Steerable Diagnostic EP Catheters are identical to the predicate devices. There are no changes to the claims, clinical applications, patient population, performance specifications, or method of operation. In addition, Innovative Health's reprocessing of these devices includes removal of visible soil and decontamination. Each device is inspected and function tested prior to packaging and labeling.
Functional and Safety Testing:
Bench and laboratory testing was conducted to demonstrate performance (safety and effectiveness) of the Reprocessed Inquiry Optima and Inquiry Optima Plus Steerable Diagnostic EP Catheter. This included the following:
- Biocompatibility
- Cleaning Validation ●
- Sterilization Validation ●
- Functional Testing ●
- Visual Inspection
- Dimensional Verification ●
- Electrical Continuity and Resistance ●
- Simulated Use ●
- Mechanical Characteristics
6
- Electrical Safety Testing .
- · Dielectric and Current Leakage
- . Packaging Validation
The Reprocessed Inquiry Optima and Inquiry Optima Plus Steerable Diagnostic EP Catheters are reprocessed no more than one (1) time. Each device is marked and tracked. After the device has reached the maximum number of reprocessing cycles, the device is rejected from further reprocessing is performed only by Innovative Health. Innovative Health restricts its reprocessing to exclude devices previously reprocessed by other reprocessors.
Conclusion:
Innovative Health concludes that the Reprocessed Inquiry Optima and Inquiry Optima Plus Steerable Diagnostic EP Catheters are as safe and effective as the predicate devices described herein.